America’s Bitter Pill: Money, Politics, Backroom Deals, and the Fight to Fix Our Broken Healthcare System
America’s Bitter Pill: Money, Politics, Backroom Deals, and the Fight to Fix Our Broken Healthcare System

Book review: America’s Bitter Pill by Steven Brill



Health care in the United States is a racket.

Steven Brill, the author of America's Bitter Pill: Money, Politics, Backroom Deals, and the Fight to Fix Our Broken Healthcare System, doesn't quite put it like that.

Instead, he highlights story after story of how bad insurance policies ruin lives by leaving families bankrupt while wrestling with terminal illness; how pharmaceutical companies extract stratospheric profit margins while hospitals prescribe too much care at prices unrelated to its cost; how hospital debt collection officers harass patients for money in the emergency room immediately before life-or-death heart surgery.

But what else is there to call an industry that systematically impoverishes its most vulnerable customers, with the full consent of the law, in exchange for what in other developed countries is a fundamental right? Where pharmaceutical companies, hospitals, medical device providers and insurance companies wield enough political influence to torpedo any reform that doesn’t offer them guaranteed increases in their bottom lines?

Brill’s book performs an admirable job of getting behind the scenes of the White House decision to tell us the story of the genesis and implementation of Obamacare. He combines this with more than enough of the two-a-penny accounts of victims of the US healthcare system – individuals who have been exploited in moments of need by companies whose putative raison d’être is to save and improve lives.

The vicissitudes of the US’s healthcare system have been well documented before Brill.

In combination with his reporting on Obamacare’s origins, passage and implementation, from Kentucky’s Kynect healthcare commerce platform, to Silicon Valley-inspired insurer Oscar, Brill shares his own harrowing experiences on the gurney as he was wheeled into New York Presbyterian Hospital for an operation to correct an aortic aneurysm.

Brill’s account is a fair, exhaustive, state-of-the-nation account of the broken US healthcare system and Obama’s partially successful attempt to heal it.

q&a a high price for good health

Adam Bouyamourn explains the intricacies of ObamaCare.

How does Obamacare work?

Under the Affordable Care Act, the US government requires everyone to have insurance, either through their employer or by purchasing it themselves (the individual mandate). The governme nt provides subsidies on insurance for families earning up to 400 per cent of the poverty line. Insurers can no longer bar individuals with pre-existing conditions.

What problems remain?

The government is forbidden from negotiating with pharmaceutical companies to buy cheaper drugs. Hospitals cannot import drugs from abroad, where they would be cheaper. The pharmaceutical industry won these concessions by threatening not to support the bill. They ensure supernormal profits for drug makers. Some families will be hit by high confiscation rates at the withdrawal of subsidy — where earning an additional $50 per year can result in cuts to government support of many thousands of dollars. Hospitals still have an incentive to overprescribe health care — especially now that their customers are more likely to be able to pay their bills. The bill contains a few measures to lower costs, but not enough to slow the rapid rates of health inflation.

What does Steven Brill want to see?

He proposes vertical integration between hospitals and insurers. He notes that this would reduce hospitals’ incentives to overcharge, and inability to get away with it by exploiting the information advantage they enjoy over insurance companies.

abouyamourn@thenational.ae

Follow The National's Business section on Twitter

BACK TO ALEXANDRIA

Director: Tamer Ruggli

Starring: Nadine Labaki, Fanny Ardant

Rating: 3.5/5

What is graphene?

Graphene is a single layer of carbon atoms arranged like honeycomb.

It was discovered in 2004, when Russian-born Manchester scientists Andrei Geim and Kostya Novoselov were "playing about" with sticky tape and graphite - the material used as "lead" in pencils.

Placing the tape on the graphite and peeling it, they managed to rip off thin flakes of carbon. In the beginning they got flakes consisting of many layers of graphene. But as they repeated the process many times, the flakes got thinner.

By separating the graphite fragments repeatedly, they managed to create flakes that were just one atom thick. Their experiment had led to graphene being isolated for the very first time.

At the time, many believed it was impossible for such thin crystalline materials to be stable. But examined under a microscope, the material remained stable, and when tested was found to have incredible properties.

It is many times times stronger than steel, yet incredibly lightweight and flexible. It is electrically and thermally conductive but also transparent. The world's first 2D material, it is one million times thinner than the diameter of a single human hair.

But the 'sticky tape' method would not work on an industrial scale. Since then, scientists have been working on manufacturing graphene, to make use of its incredible properties.

In 2010, Geim and Novoselov were awarded the Nobel Prize for Physics. Their discovery meant physicists could study a new class of two-dimensional materials with unique properties. 

 

The specs

Engine: 2.0-litre 4-cylturbo

Transmission: seven-speed DSG automatic

Power: 242bhp

Torque: 370Nm

Price: Dh136,814

Nancy 9 (Hassa Beek)

Nancy Ajram

(In2Musica)

Mercer, the investment consulting arm of US services company Marsh & McLennan, expects its wealth division to at least double its assets under management (AUM) in the Middle East as wealth in the region continues to grow despite economic headwinds, a company official said.

Mercer Wealth, which globally has $160 billion in AUM, plans to boost its AUM in the region to $2-$3bn in the next 2-3 years from the present $1bn, said Yasir AbuShaban, a Dubai-based principal with Mercer Wealth.

Within the next two to three years, we are looking at reaching $2 to $3 billion as a conservative estimate and we do see an opportunity to do so,” said Mr AbuShaban.

Mercer does not directly make investments, but allocates clients’ money they have discretion to, to professional asset managers. They also provide advice to clients.

“We have buying power. We can negotiate on their (client’s) behalf with asset managers to provide them lower fees than they otherwise would have to get on their own,” he added.

Mercer Wealth’s clients include sovereign wealth funds, family offices, and insurance companies among others.

From its office in Dubai, Mercer also looks after Africa, India and Turkey, where they also see opportunity for growth.

Wealth creation in Middle East and Africa (MEA) grew 8.5 per cent to $8.1 trillion last year from $7.5tn in 2015, higher than last year’s global average of 6 per cent and the second-highest growth in a region after Asia-Pacific which grew 9.9 per cent, according to consultancy Boston Consulting Group (BCG). In the region, where wealth grew just 1.9 per cent in 2015 compared with 2014, a pickup in oil prices has helped in wealth generation.

BCG is forecasting MEA wealth will rise to $12tn by 2021, growing at an annual average of 8 per cent.

Drivers of wealth generation in the region will be split evenly between new wealth creation and growth of performance of existing assets, according to BCG.

Another general trend in the region is clients’ looking for a comprehensive approach to investing, according to Mr AbuShaban.

“Institutional investors or some of the families are seeing a slowdown in the available capital they have to invest and in that sense they are looking at optimizing the way they manage their portfolios and making sure they are not investing haphazardly and different parts of their investment are working together,” said Mr AbuShaban.

Some clients also have a higher appetite for risk, given the low interest-rate environment that does not provide enough yield for some institutional investors. These clients are keen to invest in illiquid assets, such as private equity and infrastructure.

“What we have seen is a desire for higher returns in what has been a low-return environment specifically in various fixed income or bonds,” he said.

“In this environment, we have seen a de facto increase in the risk that clients are taking in things like illiquid investments, private equity investments, infrastructure and private debt, those kind of investments were higher illiquidity results in incrementally higher returns.”

The Abu Dhabi Investment Authority, one of the largest sovereign wealth funds, said in its 2016 report that has gradually increased its exposure in direct private equity and private credit transactions, mainly in Asian markets and especially in China and India. The authority’s private equity department focused on structured equities owing to “their defensive characteristics.”

UAE currency: the story behind the money in your pockets
MATCH INFO

Fixture: Thailand v UAE, Tuesday, 4pm (UAE)

TV: Abu Dhabi Sports

Company Profile

Name: HyveGeo
Started: 2023
Founders: Abdulaziz bin Redha, Dr Samsurin Welch, Eva Morales and Dr Harjit Singh
Based: Cambridge and Dubai
Number of employees: 8
Industry: Sustainability & Environment
Funding: $200,000 plus undisclosed grant
Investors: Venture capital and government

Company Profile

Name: Direct Debit System
Started: Sept 2017
Based: UAE with a subsidiary in the UK
Industry: FinTech
Funding: Undisclosed
Investors: Elaine Jones
Number of employees: 8

COMPANY PROFILE

Name: Xpanceo

Started: 2018

Founders: Roman Axelrod, Valentyn Volkov

Based: Dubai, UAE

Industry: Smart contact lenses, augmented/virtual reality

Funding: $40 million

Investor: Opportunity Venture (Asia)

A QUIET PLACE

Starring: Lupita Nyong'o, Joseph Quinn, Djimon Hounsou

Director: Michael Sarnoski

Rating: 4/5